Read the rest here:
Osmotica Pharmaceuticals plc to Present at H.C. Wainwright Bioconnect Conference
Radius Health, Inc.: Progress Since May 2020
Original post:
Radius Health, Inc.: Progress Since May 2020
VBL Therapeutics Treats First Patient in Phase 2 Randomized Controlled Study of VB-201 in COVID-19 Patients
Go here to see the original:
VBL Therapeutics Treats First Patient in Phase 2 Randomized Controlled Study of VB-201 in COVID-19 Patients
Bavarian Nordic to Host Third Quarter 2021 Results Conference Call
Continue reading here:
Bavarian Nordic to Host Third Quarter 2021 Results Conference Call
UPDATE – Rafael Pharmaceuticals Receives FDA Fast Track Designation for CPI-613® (devimistat) for the Treatment of Acute Myeloid Leukemia (AML)
Aleafia Health Enters Definitive Supply Agreement with European Pharmaceutical Producer Apipharm
Cellectis Announces Withdrawal of Follow-On Offering
Read this article:
Cellectis Announces Withdrawal of Follow-On Offering
Mereo BioPharma Provides Update on AIM Delisting and Continued Listing of its ADSs on Nasdaq, and Provides Update on agreements with Silicon Valley…
Chiasma to Host an Expert Panel on Acromegaly and the MPOWERED® Phase 3 Trial Results
Matinas BioPharma Awarded up to $3.75 Million from the Cystic Fibrosis Foundation to Support Development of Oral Amikacin (MAT2501) for the Treatment…
Homology Medicines Announces Presentation of Positive Data from the Dose-Escalation Phase of the pheNIX Gene Therapy Trial for Adults with PKU
BioDelivery Sciences to Participate in the Piper Sandler 32nd Annual Healthcare Conference
Iovance Biotherapeutics to Host Third Quarter 2020 Financial Results Conference Call and Webcast on Thursday, November 5, 2020
Outlook Therapeutics Secures $10 Million in Additional Working Capital
Spring Bank Pharmaceuticals Announces Special Dividend of Contingent Value Rights
See the original post:
Spring Bank Pharmaceuticals Announces Special Dividend of Contingent Value Rights
Trevi Therapeutics Provides Clinical Trial Updates for Haduvio™
Continue reading here:
Trevi Therapeutics Provides Clinical Trial Updates for Haduvio™